<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://teaching.ncl.ac.uk/bms/wiki//index.php?action=history&amp;feed=atom&amp;title=Cystic_fibrosis-related_diabetes</id>
	<title>Cystic fibrosis-related diabetes - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://teaching.ncl.ac.uk/bms/wiki//index.php?action=history&amp;feed=atom&amp;title=Cystic_fibrosis-related_diabetes"/>
	<link rel="alternate" type="text/html" href="https://teaching.ncl.ac.uk/bms/wiki//index.php?title=Cystic_fibrosis-related_diabetes&amp;action=history"/>
	<updated>2026-04-10T15:03:35Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.0</generator>
	<entry>
		<id>https://teaching.ncl.ac.uk/bms/wiki//index.php?title=Cystic_fibrosis-related_diabetes&amp;diff=12344&amp;oldid=prev</id>
		<title>Nnjm2 at 23:38, 26 November 2014</title>
		<link rel="alternate" type="text/html" href="https://teaching.ncl.ac.uk/bms/wiki//index.php?title=Cystic_fibrosis-related_diabetes&amp;diff=12344&amp;oldid=prev"/>
		<updated>2014-11-26T23:38:38Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 23:38, 26 November 2014&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;amp;nbsp;&lt;/del&gt;Cystic fibrosis-related diabetes (CFRD), is a possible side effect of [[&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Cystic_fibrosis&lt;/del&gt;|cystic fibrosis&amp;amp;nbsp;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;]]&lt;/del&gt;(CF) which affects 17% of the United Kingdom&#039;s CF sufferers&amp;lt;ref&amp;gt;Wickens-Mitchell, K., Gilchrist, F. and Lenney, W. 2012. P86 The Screening and Diagnosis of Cystic Fibrosis-Related Diabetes in the United Kingdom. Thorax, 67 (Suppl 2), pp. 101--101.&amp;lt;/ref&amp;gt;. Thick mucus secretions (a symptom of [[Cystic fibrosis|CF]]) cause damage to the insulin-producing cells in the pancreas ([[Islet of Langerhans|Islets of Langerhans]]). Whilst CFRD shares characteristics with both [[Type 1 diabetes|type 1]] and [[Type 2 diabetes|type 2]] [[Diabetes|diabetes]], it is treated as its own distinct class&amp;lt;ref&amp;gt;Moran, A., Brunzell, C., Cohen, R., Katz, M., Marshall, B., Onady, G., Robinson, K., Sabadosa, K., Stecenko, A. and Slovis, B. (2010). Clinical Care Guidelines for Cystic Fibrosis-Related Diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care, 33(12), pp.2697-2708.&amp;lt;/ref&amp;gt;. CFRD results in a drastically reduced lifespan in female CF sufferes, but not in males&amp;lt;ref&amp;gt;Milla, C., Billings, J. and Moran, A. (2005). Diabetes Is Associated With Dramatically Decreased Survival in Female but Not Male Subjects With Cystic Fibrosis. Diabetes Care, 28(9), pp.2141-2144.&amp;lt;/ref&amp;gt;.  &lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Cystic fibrosis-related diabetes (CFRD), is a possible side effect of [[&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Cystic fibrosis&lt;/ins&gt;|cystic fibrosis&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;]]&lt;/ins&gt;&amp;amp;nbsp;(CF) which affects 17% of the United Kingdom&#039;s CF sufferers&amp;lt;ref&amp;gt;Wickens-Mitchell, K., Gilchrist, F. and Lenney, W. 2012. P86 The Screening and Diagnosis of Cystic Fibrosis-Related Diabetes in the United Kingdom. Thorax, 67 (Suppl 2), pp. 101--101.&amp;lt;/ref&amp;gt;. Thick &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[&lt;/ins&gt;mucus&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;|mucus]] &lt;/ins&gt;secretions (a symptom of [[Cystic fibrosis|CF]]) cause damage to the insulin-producing cells in the pancreas ([[Islet of Langerhans|Islets of Langerhans]]). Whilst CFRD shares characteristics with both [[Type 1 diabetes|type 1]] and [[Type 2 diabetes|type 2]] [[Diabetes|diabetes]], it is treated as its own distinct class&amp;lt;ref&amp;gt;Moran, A., Brunzell, C., Cohen, R., Katz, M., Marshall, B., Onady, G., Robinson, K., Sabadosa, K., Stecenko, A. and Slovis, B. (2010). Clinical Care Guidelines for Cystic Fibrosis-Related Diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care, 33(12), pp.2697-2708.&amp;lt;/ref&amp;gt;. CFRD results in a drastically reduced lifespan in female CF sufferes, but not in males&amp;lt;ref&amp;gt;Milla, C., Billings, J. and Moran, A. (2005). Diabetes Is Associated With Dramatically Decreased Survival in Female but Not Male Subjects With Cystic Fibrosis. Diabetes Care, 28(9), pp.2141-2144.&amp;lt;/ref&amp;gt;.&amp;lt;br&amp;gt;  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt; &lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;  &lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== References  ===&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== References  ===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;references /&amp;gt;  &lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;references /&amp;gt;&amp;lt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;br&lt;/ins&gt;&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt; &lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;references /&amp;gt; &lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt; &lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;references /&lt;/del&gt;&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Nnjm2</name></author>
	</entry>
	<entry>
		<id>https://teaching.ncl.ac.uk/bms/wiki//index.php?title=Cystic_fibrosis-related_diabetes&amp;diff=12316&amp;oldid=prev</id>
		<title>140039373 at 23:00, 26 November 2014</title>
		<link rel="alternate" type="text/html" href="https://teaching.ncl.ac.uk/bms/wiki//index.php?title=Cystic_fibrosis-related_diabetes&amp;diff=12316&amp;oldid=prev"/>
		<updated>2014-11-26T23:00:51Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 23:00, 26 November 2014&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;amp;nbsp;Cystic fibrosis-related diabetes (CFRD), is a possible side effect of [[&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Cystic_Fibrosis&lt;/del&gt;|cystic fibrosis&amp;amp;nbsp;]](CF) which affects 17% of the United Kingdom&#039;s CF sufferers&amp;lt;ref&amp;gt;Wickens-Mitchell, K., Gilchrist, F. and Lenney, W. 2012. P86 The Screening and Diagnosis of Cystic Fibrosis-Related Diabetes in the United Kingdom. Thorax, 67 (Suppl 2), pp. 101--101.&amp;lt;/ref&amp;gt;. Thick mucus secretions (a symptom of [[Cystic fibrosis|CF]]) cause damage to the insulin-producing cells in the pancreas ([[Islet of Langerhans|Islets of Langerhans]]). Whilst CFRD shares characteristics with both [[Type 1 diabetes|type 1]] and [[Type 2 diabetes|type 2]] [[Diabetes|diabetes]], it is treated as its own distinct class&amp;lt;ref&amp;gt;Moran, A., Brunzell, C., Cohen, R., Katz, M., Marshall, B., Onady, G., Robinson, K., Sabadosa, K., Stecenko, A. and Slovis, B. (2010). Clinical Care Guidelines for Cystic Fibrosis-Related Diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care, 33(12), pp.2697-2708.&amp;lt;/ref&amp;gt;. CFRD results in a drastically reduced lifespan in female CF sufferes, but not in males&amp;lt;ref&amp;gt;Milla, C., Billings, J. and Moran, A. (2005). Diabetes Is Associated With Dramatically Decreased Survival in Female but Not Male Subjects With Cystic Fibrosis. Diabetes Care, 28(9), pp.2141-2144.&amp;lt;/ref&amp;gt;.  &lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;amp;nbsp;Cystic fibrosis-related diabetes (CFRD), is a possible side effect of [[&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Cystic_fibrosis&lt;/ins&gt;|cystic fibrosis&amp;amp;nbsp;]](CF) which affects 17% of the United Kingdom&#039;s CF sufferers&amp;lt;ref&amp;gt;Wickens-Mitchell, K., Gilchrist, F. and Lenney, W. 2012. P86 The Screening and Diagnosis of Cystic Fibrosis-Related Diabetes in the United Kingdom. Thorax, 67 (Suppl 2), pp. 101--101.&amp;lt;/ref&amp;gt;. Thick mucus secretions (a symptom of [[Cystic fibrosis|CF]]) cause damage to the insulin-producing cells in the pancreas ([[Islet of Langerhans|Islets of Langerhans]]). Whilst CFRD shares characteristics with both [[Type 1 diabetes|type 1]] and [[Type 2 diabetes|type 2]] [[Diabetes|diabetes]], it is treated as its own distinct class&amp;lt;ref&amp;gt;Moran, A., Brunzell, C., Cohen, R., Katz, M., Marshall, B., Onady, G., Robinson, K., Sabadosa, K., Stecenko, A. and Slovis, B. (2010). Clinical Care Guidelines for Cystic Fibrosis-Related Diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care, 33(12), pp.2697-2708.&amp;lt;/ref&amp;gt;. CFRD results in a drastically reduced lifespan in female CF sufferes, but not in males&amp;lt;ref&amp;gt;Milla, C., Billings, J. and Moran, A. (2005). Diabetes Is Associated With Dramatically Decreased Survival in Female but Not Male Subjects With Cystic Fibrosis. Diabetes Care, 28(9), pp.2141-2144.&amp;lt;/ref&amp;gt;.  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;  &lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>140039373</name></author>
	</entry>
	<entry>
		<id>https://teaching.ncl.ac.uk/bms/wiki//index.php?title=Cystic_fibrosis-related_diabetes&amp;diff=12310&amp;oldid=prev</id>
		<title>140039373: Cystic fibrosis-related diabetes (CFRD) is a possible symptom of cystic fibrosis.</title>
		<link rel="alternate" type="text/html" href="https://teaching.ncl.ac.uk/bms/wiki//index.php?title=Cystic_fibrosis-related_diabetes&amp;diff=12310&amp;oldid=prev"/>
		<updated>2014-11-26T22:58:19Z</updated>

		<summary type="html">&lt;p&gt;Cystic fibrosis-related diabetes (CFRD) is a possible symptom of cystic fibrosis.&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;amp;nbsp;Cystic fibrosis-related diabetes (CFRD), is a possible side effect of [[Cystic_Fibrosis|cystic fibrosis&amp;amp;nbsp;]](CF) which affects 17% of the United Kingdom&amp;#039;s CF sufferers&amp;lt;ref&amp;gt;Wickens-Mitchell, K., Gilchrist, F. and Lenney, W. 2012. P86 The Screening and Diagnosis of Cystic Fibrosis-Related Diabetes in the United Kingdom. Thorax, 67 (Suppl 2), pp. 101--101.&amp;lt;/ref&amp;gt;. Thick mucus secretions (a symptom of [[Cystic fibrosis|CF]]) cause damage to the insulin-producing cells in the pancreas ([[Islet of Langerhans|Islets of Langerhans]]). Whilst CFRD shares characteristics with both [[Type 1 diabetes|type 1]] and [[Type 2 diabetes|type 2]] [[Diabetes|diabetes]], it is treated as its own distinct class&amp;lt;ref&amp;gt;Moran, A., Brunzell, C., Cohen, R., Katz, M., Marshall, B., Onady, G., Robinson, K., Sabadosa, K., Stecenko, A. and Slovis, B. (2010). Clinical Care Guidelines for Cystic Fibrosis-Related Diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care, 33(12), pp.2697-2708.&amp;lt;/ref&amp;gt;. CFRD results in a drastically reduced lifespan in female CF sufferes, but not in males&amp;lt;ref&amp;gt;Milla, C., Billings, J. and Moran, A. (2005). Diabetes Is Associated With Dramatically Decreased Survival in Female but Not Male Subjects With Cystic Fibrosis. Diabetes Care, 28(9), pp.2141-2144.&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt; &lt;br /&gt;
&lt;br /&gt;
=== References  ===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;references /&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>140039373</name></author>
	</entry>
</feed>